Supply for Development Sample Clauses

The 'Supply for Development' clause defines the obligations and procedures for providing goods, materials, or services necessary for a project's development phase. Typically, it outlines what items or resources must be supplied, the timeline for delivery, and any quality or compliance standards that must be met. For example, a contractor may be required to deliver specific equipment or technical documentation before construction can begin. This clause ensures that all parties understand their responsibilities regarding the timely and adequate supply of essential inputs, thereby preventing delays and disputes during the development process.
Supply for Development. If requested by Licensee by written notice, Ipsen shall manufacture and supply, or cause to be manufactured and supplied, [ ]* in sufficient quantities to satisfy the reasonable requirements of Licensee and its Sublicensees and Contractors for use of such [ ]* in Development activities with respect to such Licensed Product until the end of [ ]* for such Licensed Product. ▇▇▇▇▇’▇ supply of [ ]* to Licensee under this Section 8.1 shall be provided at ▇▇▇▇▇’▇ Manufacturing Cost. Promptly following Licensee’s notice, the Parties shall enter into a clinical supply agreement and a technical agreement with respect to such clinical supplies (the “Clinical Supply Agreements”) (1). ▇▇▇▇▇’▇ Manufacturing Cost will be agreed upon in the Clinical Supply Agreements (to reflect ▇▇▇▇▇’▇ actual costs for manufacturing the [ ]* as well as a mechanism for adjusting such Manufacturing Cost in case of increase or decrease of any component of such Manufacturing Cost. The Clinical Supply Agreements will provide for the terms and conditions of the transfer of ▇▇▇▇▇’▇ manufacturing technology at the end of [ ]*, provided, however, that the Parties agree that such transfer will be made at Licensee’s cost and expense, less an amount equal to the ▇▇▇▇▇ Manufacturing Transfer Cost, to be estimated and agreed by the parties in good faith. For the avoidance of doubt, in the event Licensee does not notify Ipsen with its request for the manufacturing by Ipsen of [ ]* pursuant to this Section 8.1, the transfer of manufacturing technology shall be made under the terms and conditions of Section 8.1. Ipsen shall not be obligated to manufacture any quantities of [ ]* pursuant to this Section 8.1 if and to the extent that such quantities will be used by Licensee or any of its Sublicensees or Contractors to make finished Licensed Product for use in [ ]*.
Supply for Development. Amylin shall supply ACTII, without cost to ACTII, with sufficient quantities of Field Products for ACTII to conduct all the activities described in the Product Development Plan.
Supply for Development. As and to the extent requested by ▇▇▇▇▇▇, ▇▇▇▇ shall manufacture and supply to ▇▇▇▇▇▇, in accordance with Section 3.1, ▇▇▇▇ Products for purposes of developing and/or obtaining regulatory approval of the ▇▇▇▇ Products or End Products (including for non-clinical and clinical studies) and other similar and related purposes at the Development Transfer Price, but not for commercial sale. ▇▇▇▇▇▇ shall keep ▇▇▇▇ reasonably informed of its anticipated requirements of ▇▇▇▇ Products for such purposes, whether through the Project Manager meetings pursuant to Section 2.3 (if applicable), or otherwise. ▇▇▇▇▇▇ may order ▇▇▇▇ Products for the development-related purposes described above under this Section 3.2 from ▇▇▇▇ by providing ▇▇▇▇ with a binding purchase order indicating: (i) the quantities of ▇▇▇▇ Product ordered (provided such quantities are consistent with the terms of this Agreement), (ii) the requested delivery date [****], and (iii) a delivery location. Upon receipt of any such conforming purchase order, ▇▇▇▇ shall manufacture and supply ▇▇▇▇ Product in accordance therewith. Any term in such purchase order that is inconsistent with this Agreement shall not be binding upon ▇▇▇▇; otherwise ▇▇▇▇ shall send a confirmation to ▇▇▇▇▇▇ within [****] of receiving any such conforming purchase order. “Development Transfer Price” means [****].
Supply for Development. At Adolor’s sole option, EpiCept shall be responsible to supply, or to obtain supply, for Adolor’s requirements in the Territory of Licensed Product for clinical and other development activities in accordance with Adolor’s obligations under this Agreement. Alternatively, Adolor, in its sole discretion, shall be entitled to supply and manufacture clinical supplies of Licensed Product in the Territory. The Parties acknowledge that Third Party subcontractors may be engaged by Adolor to carry out such manufacture and supply on Adolor’s behalf. Within sixty (60) days after the Effective Date, in the amounts and at a price per patch set forth on Schedule 3.10(a), EpiCept shall deliver to a location designated by Adolor LidoPAIN® SP Product 9.5% patches and LidoPAIN® SP Product placebo 0.0% patches that are stored at PharmaForm.
Supply for Development. The Lead Development Party is entitled to either engage a Third Party to manufacture and supply such quantities of Collaboration Product as may be required for Development, or to manufacture and supply itself all or a portion of the Collaboration Product required for Development, but in any event shall do one of the foregoing so that the Collaboration Product is supplied. If Nuvelo manufactures, the Collaboration Product shall be supplied at [*] of Manufacturing Costs. If a Third Party manufactures, then the Collaboration Product shall be supplied at [*] of the price charged by the Third Party, and the time spent by Nuvelo FTEs to manage the Third Party supplier shall be excluded from the calculation of Manufacturing Costs, Development Costs and Allowable Commercialization Expenses. Manufacturing Costs for Development (with the [*]) are incorporated into Development Costs to the full extent provided in the Financial Appendix.
Supply for Development. CancerVax shall use Commercially Reasonable Efforts to supply the Parties with Product for use in the Development of the Product, as specified in the Development Plan, and for use in Phase IV Clinical Trials, and shall deliver Product requested by Serono as directed from time to time. The costs of such Product shall be calculated as the Cost of Goods. Serono shall pay CancerVax for all amounts of Product required by Serono pursuant to this Section 8.1, and CancerVax shall accrue the Cost of Goods of all amounts of Product required by CancerVax pursuant to this Section 8.1, and such payments and accruals shall be deemed a Development Expense or a Commercial Expense, as applicable.